Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals

The Genotype to Phenotype Japan (G2P-Japan) Consortium

doi:10.1016/S1473-3099(23)00784-3

Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals

The Genotype to Phenotype Japan (G2P-Japan) Consortium

臨床検査医学

研究成果: Letter › 査読

15 被引用数 (Scopus)

本文言語	English
ページ（範囲）	e147-e148
ジャーナル	The Lancet Infectious Diseases
巻	24
号	3
DOI	https://doi.org/10.1016/S1473-3099(23)00784-3
出版ステータス	Published - 2024 3月

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

SDG 3 すべての人に健康と福祉を

ASJC Scopus subject areas

感染症

文献へのアクセス

10.1016/S1473-3099(23)00784-3

他のファイルとリンク

引用スタイル

@article{0f9305104f3a42418352776e920ce029,

title = "Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals",

author = "\{The Genotype to Phenotype Japan (G2P-Japan) Consortium\} and Yusuke Kosugi and Yu Kaku and Hinay, \{Alfredo A.\} and Ziyi Guo and Keiya Uriu and Minoru Kihara and Fumitake Saito and Yoshifumi Uwamino and Jin Kuramochi and Kotaro Shirakawa and Akifumi Takaori-Kondo and Kei Sato",

year = "2024",

month = mar,

doi = "10.1016/S1473-3099(23)00784-3",

language = "English",

volume = "24",

pages = "e147--e148",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Ltd",

number = "3",

}

TY - JOUR

T1 - Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals

AU - The Genotype to Phenotype Japan (G2P-Japan) Consortium

AU - Kosugi, Yusuke

AU - Kaku, Yu

AU - Hinay, Alfredo A.

AU - Guo, Ziyi

AU - Uriu, Keiya

AU - Kihara, Minoru

AU - Saito, Fumitake

AU - Uwamino, Yoshifumi

AU - Kuramochi, Jin

AU - Shirakawa, Kotaro

AU - Takaori-Kondo, Akifumi

AU - Sato, Kei

PY - 2024/3

Y1 - 2024/3

UR - https://www.scopus.com/pages/publications/85185839154

UR - https://www.scopus.com/pages/publications/85185839154#tab=citedBy

U2 - 10.1016/S1473-3099(23)00784-3

DO - 10.1016/S1473-3099(23)00784-3

M3 - Letter

C2 - 38211599

AN - SCOPUS:85185839154

SN - 1473-3099

VL - 24

SP - e147-e148

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 3

ER -